|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.430 USD | +19.17% |
|
+123.93% | -52.33% |
| Nov. 21 | CbdMD reports preliminary unaudited fourth quarter results | RE |
| Nov. 21 | CbdMD, Inc. Reports Preliminary Earnings Results for the Fourth Quarter and Year Ended September 30, 2025 | CI |
Company Valuation: cbdMD, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: September | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 104.2 | 120.2 | 13.63 | 2.958 | 1.804 | 10.7 | - |
| Change | - | 15.32% | -88.66% | -78.3% | -39.01% | 492.86% | - |
| Enterprise Value (EV) | 89.71 | 93.93 | 13.63 | 2.958 | 1.804 | 10.7 | 10.7 |
| Change | - | 4.71% | -85.49% | -78.3% | -39.01% | 492.86% | 0% |
| P/E ratio | 7.14x | -4.43x | -0.18x | -0.08x | -0.26x | -1.11x | -6x |
| PBR | - | - | - | - | - | - | - |
| PEG | - | 0x | -0x | 0x | 0x | 0x | 0.1x |
| Capitalization / Revenue | 2.49x | 2.7x | - | 0.12x | 0.09x | 0.56x | 0.53x |
| EV / Revenue | 0x | 0x | - | 0x | 0x | 0.56x | 0.53x |
| EV / EBITDA | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | - | -0x | -0x | -5.06x | -4.61x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | 100.8 | -169.2 | -446.4 | -106.6 | -14.32 | -1.08 | -0.2 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 41.88 | 44.48 | - | 24.16 | 19.48 | 19.17 | 20.12 |
| EBITDA | -16.86 | -18.6 | - | - | - | - | - |
| EBIT 1 | -17.58 | -19.62 | - | -5.527 | -1.592 | -2.112 | -2.321 |
| Net income 1 | 12.24 | -25.95 | -70.08 | -26.94 | -7.704 | -4.446 | -2.321 |
| Net Debt | -14.5 | -26.24 | - | - | - | - | - |
| Reference price 2 | 720.000 | 748.800 | 81.036 | 8.280 | 3.760 | 1.200 | 1.200 |
| Nbr of stocks (in thousands) | 145 | 160 | 168 | 357 | 480 | 8,913 | - |
| Announcement Date | 12/22/20 | 12/17/21 | 12/15/22 | 12/22/23 | 12/18/24 | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.11x | - | - | - | 10.7M | |
| 46.44x | 15.35x | 34.02x | 0.55% | 951B | |
| 20.48x | 5.68x | 15.73x | 2.41% | 516B | |
| 52.06x | 7.52x | 17.8x | 2.87% | 402B | |
| 18.68x | 4.69x | 11.74x | 3.07% | 346B | |
| 27.43x | 5.19x | 15.4x | 1.77% | 282B | |
| 18.61x | 5.02x | 11.82x | 3.03% | 259B | |
| 12.96x | 4.23x | 9.08x | 3.23% | 249B | |
| 13.72x | 4.91x | 10.16x | 3.68% | 221B | |
| 25.64x | 6.05x | 10.4x | 2.94% | 175B | |
| Average | 23.49x | 6.51x | 15.13x | 2.62% | 340.15B | |
| Weighted average by Cap. | 31.00x | 8.27x | 19.24x | 2.18% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- YCBD Stock
- Valuation cbdMD, Inc.
Select your edition
All financial news and data tailored to specific country editions
